Linda Bain
VP, Fin. & Business Operations, bluebird bio.
Companies
- Hemab Therapeutics Holdings, Inc.Board member Apr 30, 2026 to now1
- Autolus TherapeuticsBoard member Mar 18, 2026 to now2
- Arvinas (United States)Board member Jun 12, 2020 to now3
- Codiak BioSciences, Inc.Chief financial officer Oct 13, 2020 to Mar 30, 20234
- VBI Vaccines Inc/BCBoard member Jul 7, 2021 to Jan 31, 20225
- Avalanche BiotechnologiesChief financial officer Jul 30, 2014 to Aug 25, 20156
- bluebird bioVP, Fin. & Business Operations Jun 18, 2013 to Mar 5, 20147
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Arvinas (United States) ARVN41,572 shares8$298.7K at $7.18Jun 24, 2026
- Codiak BioSciences, Inc.0 shares9Mar 28, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 24, 2026Granted 15,527 shares of Arvinas (United States)8
- Jun 25, 2025Granted 16,025 shares of Arvinas (United States)10
- May 29, 2024Granted 5,899 shares of Arvinas (United States)11
- Jun 15, 2023Granted 4,121 shares of Arvinas (United States)12
- Mar 28, 2023Sold 13,412 shares at $0.17 of Codiak BioSciences, Inc.9
- Feb 17, 2023Sold 2,570 shares at $0.59 of Codiak BioSciences, Inc.13
- Feb 16, 2023Exercised options 7,613 shares of Codiak BioSciences, Inc.13
- Jan 20, 2023Sold 1,880 shares at $0.58 of Codiak BioSciences, Inc.14
- Jan 19, 2023Exercised options 5,000 shares of Codiak BioSciences, Inc.14
- Aug 17, 2022Sold 2,364 shares at $2.21 of Codiak BioSciences, Inc.13
- Aug 16, 2022Exercised options 7,613 shares of Codiak BioSciences, Inc.13
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARAutolus Therapeutics, Board member
- 3
- 4
- 5SEC EDGARVBI Vaccines Inc/BC, Board member
- 6
- 7
- 8
- 9
- 10SEC EDGARForm 4 filed Jun 27, 2025
- 11SEC EDGARForm 4 filed May 31, 2024
- 12SEC EDGARForm 4 filed Jun 20, 2023
- 13SEC EDGARForm 4 filed Feb 21, 2023
- 14SEC EDGARForm 4 filed Jan 23, 2023